Chronic treatment with quercetin prevents negative consequences of doxorubicin treatment in the heart tissue and improves postischemic recovery of heart function in doxorubicin-treated rats

被引：0
|
作者：
Bartekova, M. [1 ,3 ]
Dovinova, I. [2 ]
Tribulova, N. [1 ]
Okruhlicova, L. [1 ]
Radosinska, J. [1 ,3 ]
Ferenczyova, K. [1 ]
Fogarassyova, M. [1 ]
Barancik, M. [1 ]
机构：
[1] Slovak Acad Sci, Heart Res Inst, Bratislava, Slovakia
[2] Slovak Acad Sci, Inst Normal & Pathol Physiol, Bratislava, Slovakia
[3] Comenius Univ, Inst Physiol, Fac Med, Bratislava, Slovakia
来源：
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2017年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
86
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [21] Salsolinol Attenuates Doxorubicin-Induced Chronic Heart Failure in Rats and Improves Mitochondrial Function in H9c2 Cardiomyocytes
    Wen, Jianxia
    Zhang, Lu
    Liu, Honghong
    Wang, Jiabo
    Li, Jianyu
    Yang, Yuxue
    Wang, Yingying
    Cai, Huadan
    Li, Ruisheng
    Zhao, Yanling
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [22] Treatment with the SGLT2 inhibitor empagliflozin improves cardiac function in rats with chronic heart failure
    Soulie, M.
    Stephan, Y.
    Nicol, L.
    Henry, J. -P.
    Richard, V.
    Pieper, M. P.
    Mulder, P.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S436 - S436
  • [23] Long-term empagliflozin treatment improves cardiac function and remodeling in rats with chronic heart failure
    Stephan, Y.
    Soulie, M.
    Peschanski, N.
    Nicol, L.
    Henry, J. P.
    Richard, V.
    Pieper, M. P.
    Mulder, P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 284 - 284
  • [24] Short and Long-term Empagliflozin Treatment Improves Cardiac Function in Rats with Chronic Heart Failure
    Soulie, M.
    Stephan, Y.
    Nicol, L.
    Henry, J. P.
    Richard, V.
    Pieper, M.
    Mulder, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 30 - 30
  • [25] Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure
    Delgado, RM
    Nawar, MA
    Zewail, AM
    Kar, B
    Vaughn, WK
    Wu, KK
    Aleksic, N
    Sivasubramanian, N
    McKay, K
    Mann, DL
    Willerson, JT
    CIRCULATION, 2004, 109 (11) : 1428 - 1433
  • [26] Prophylactic combined heart failure treatment attenuates the development of doxorubicin induced systolic and diastolic dysfunction in rats
    Lodi, M.
    Priksz, D.
    Fulop, G. A.
    Kocsis, J.
    Edes, I.
    Czuriga, I.
    Kisvarday, Z.
    Juhasz, B.
    Toth, A.
    Papp, Z.
    Czuriga, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 5 - 6
  • [27] Chronic clenbuterol treatment improves heart and myocyte function in heart failure, with and without mechanical unloading.
    Soppa, Gopal K.
    Lee, Joon
    Stagg, Mark A.
    Youssef, Samuel
    Siedlecka, Urszula
    Yacoub, Magdi H.
    Terracciano, Cesare M.
    CIRCULATION, 2006, 114 (18) : 483 - 483
  • [28] Mitochondrionopathy Phenotype in Doxorubicin-Treated Wistar Rats Depends on Treatment Protocol and Is Cardiac-Specific (vol 7, e38867, 2012)
    Pereira, G. C.
    Pereira, S. P.
    Pereira, C., V
    Lumini, J. A.
    Magalhaes, J.
    PLOS ONE, 2014, 9 (05):
  • [29] Short- and Long-Term Empagliflozin Treatment Improves Cardiac Function in Rats with Chronic Heart Failure
    Soulie, Matthieu
    Stephan, Yohan
    Nicol, Lionel
    Henry, Jean-Paul
    Richard, Vincent
    Pieper, Michael
    Mulder, Paul
    DIABETES, 2020, 69
  • [30] FATAL CONGESTIVE HEART-FAILURE FOLLOWING MITOXANTRONE TREATMENT IN 2 CHILDREN PREVIOUSLY TREATED WITH DOXORUBICIN AND CISPLATIN
    PRATT, CB
    CROM, DB
    WALLENBERG, J
    SANYAL, SK
    MILIAUSKAS, J
    SOHLBERG, K
    CANCER TREATMENT REPORTS, 1983, 67 (01): : 85 - 88
12345